Harrow Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. (NASDAQ: HROW) on March 31, 2022. The filing reports material corporate governance changes regarding the Board of Directors effective immediately on the date of the report.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or performance metrics.
Material Changes
- Resignation: Dr. Robert J. Kammer resigned as a member of the Board of Directors effective March 31, 2022. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Advisory Role: Dr. Kammer has been retained as a special advisor to the Company and the Board through the end of 2022.
- Board Expansion: The Board size was increased to six members.
- New Appointments: Mr. Perry J. Sternberg and Dr. Marty Makary were appointed to fill the vacancies created by Dr. Kammer's resignation and the Board expansion. Both are independent directors.
- Committee Assignments: Mr. Sternberg will serve on the Compensation Committee, and Dr. Makary will serve on the Audit Committee.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies related to financial operations were disclosed in this report. The new directors will receive the Company's standard director's compensation package, including cash and equity.
Key Facts for Investor Verification
- Verify the independence status and potential conflicts of interest for new directors Perry J. Sternberg and Marty Makary.
- Confirm the terms of Dr. Robert J. Kammer's advisory agreement and any associated compensation.
- Review the Company's most recent proxy statement for details on the standard director compensation package.
- Monitor upcoming filings for the impact of these governance changes on strategic direction.